PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AMPH vs. NVO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AMPH and NVO is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

AMPH vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amphastar Pharmaceuticals, Inc. (AMPH) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

300.00%400.00%500.00%600.00%700.00%JulyAugustSeptemberOctoberNovemberDecember
347.31%
353.56%
AMPH
NVO

Key characteristics

Sharpe Ratio

AMPH:

-0.85

NVO:

-0.43

Sortino Ratio

AMPH:

-1.09

NVO:

-0.37

Omega Ratio

AMPH:

0.86

NVO:

0.95

Calmar Ratio

AMPH:

-0.77

NVO:

-0.36

Martin Ratio

AMPH:

-1.15

NVO:

-1.15

Ulcer Index

AMPH:

28.73%

NVO:

13.25%

Daily Std Dev

AMPH:

38.99%

NVO:

35.35%

Max Drawdown

AMPH:

-49.92%

NVO:

-71.30%

Current Drawdown

AMPH:

-39.78%

NVO:

-41.92%

Fundamentals

Market Cap

AMPH:

$1.96B

NVO:

$486.49B

EPS

AMPH:

$3.01

NVO:

$2.99

PE Ratio

AMPH:

13.57

NVO:

36.12

PEG Ratio

AMPH:

2.77

NVO:

1.61

Total Revenue (TTM)

AMPH:

$721.15M

NVO:

$270.58B

Gross Profit (TTM)

AMPH:

$374.85M

NVO:

$229.07B

EBITDA (TTM)

AMPH:

$267.92M

NVO:

$135.97B

Returns By Period

In the year-to-date period, AMPH achieves a -36.72% return, which is significantly lower than NVO's -16.93% return. Over the past 10 years, AMPH has underperformed NVO with an annualized return of 12.74%, while NVO has yielded a comparatively higher 17.16% annualized return.


AMPH

YTD

-36.72%

1M

-11.23%

6M

-3.24%

1Y

-34.72%

5Y*

14.84%

10Y*

12.74%

NVO

YTD

-16.93%

1M

-19.26%

6M

-39.90%

1Y

-16.95%

5Y*

26.03%

10Y*

17.16%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AMPH vs. NVO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for AMPH, currently valued at -0.85, compared to the broader market-4.00-2.000.002.00-0.85-0.43
The chart of Sortino ratio for AMPH, currently valued at -1.09, compared to the broader market-4.00-2.000.002.004.00-1.09-0.37
The chart of Omega ratio for AMPH, currently valued at 0.86, compared to the broader market0.501.001.502.000.860.95
The chart of Calmar ratio for AMPH, currently valued at -0.77, compared to the broader market0.002.004.006.00-0.77-0.36
The chart of Martin ratio for AMPH, currently valued at -1.15, compared to the broader market-5.000.005.0010.0015.0020.0025.00-1.15-1.15
AMPH
NVO

The current AMPH Sharpe Ratio is -0.85, which is lower than the NVO Sharpe Ratio of -0.43. The chart below compares the historical Sharpe Ratios of AMPH and NVO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.85
-0.43
AMPH
NVO

Dividends

AMPH vs. NVO - Dividend Comparison

AMPH has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 1.70%.


TTM20232022202120202019201820172016201520142013
AMPH
Amphastar Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NVO
Novo Nordisk A/S
1.70%0.99%1.18%1.34%1.86%2.12%2.47%2.12%3.93%1.31%1.96%1.72%

Drawdowns

AMPH vs. NVO - Drawdown Comparison

The maximum AMPH drawdown since its inception was -49.92%, smaller than the maximum NVO drawdown of -71.30%. Use the drawdown chart below to compare losses from any high point for AMPH and NVO. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-39.78%
-41.92%
AMPH
NVO

Volatility

AMPH vs. NVO - Volatility Comparison

The current volatility for Amphastar Pharmaceuticals, Inc. (AMPH) is 8.86%, while Novo Nordisk A/S (NVO) has a volatility of 20.84%. This indicates that AMPH experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
8.86%
20.84%
AMPH
NVO

Financials

AMPH vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Amphastar Pharmaceuticals, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab